Home›Companies›Biotech & Pharma›Precise Bio

Precise Bio, Inc.

Updated Oct 29, 2026·Latest SEC filing Jan 17, 2024·Suggest an edit

About Precise Bio

Precise Bio is a private company based in Winston-Salem, North Carolina. It has reported $27,530,000 raised in two offerings on Form D since February 2022.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 14, 2022Jan 17, 2024$12,000,000of $25.0M target8$1.5MEquityRule 506(b)Form D ↗
Nov 3, 2018Feb 9, 2022$15,530,000fully sold70$221KDebt, SAFE (Simple Agreement for Future Equity)Rule 506(b)Form D ↗
Total, two offerings$27,530,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Precise Bio's Form D filed Jan 17, 2024.

NC
Nathan Cali
Director
VD
Viko Dana
Director
AB
Aryeh Batt
Executive officer, director and promoter
SS
Shay Soker
Director and promoter
DM
IL
Ilan Lior
Director
OH
Ori Hadimi
Executive officer and director
AK
Avi Katz
Director
AA
Anthony Atala
Director and promoter

Earlier filings also listed Yalon Farhi (director, last listed Feb 2022).

Sources

  1. SECPrecise Bio, Inc. filing history